CooperVision’s MiSight® 1 day is the first and only contact lens FDA-approved* to slow the progression of myopia in children aged 8-12 at the initiation of treatment1. Children can apply the soft, daily wear, single use contact lenses to their eyes in the morning, wear them for at least 10 hours during the day, then dispose of them in the evening. The FDA-approved* lens is available as part of a comprehensive myopia management approach offered by CooperVision and participating eye care practitioners.
MiSight® 1 day: first and only soft contact lens FDA-approved* to slow the progression of myopia in children, aged 8-12 at the initiation of treatment1 MiSight® 1 day is an award-winning2,3,4 dual-focus soft contact lens that uses ActivControl™ Technology to slow the elongation of the eyeball1. The ActivControl™ Technology in MiSight® 1 day utilizes an optic zone concentric ring design with alternating vision correction and treatment zones. Two zones are vision correction zones with the label power of the
contact lens, and the alternating two zones are treatment zones with 2 diopters of defocus to slow the progression of myopia.
This design allows the child to see clearly while benefiting from the treatment effect.
CooperVision undertook a rigorous, multi-year, multi-country study to track how the MiSight® 1 day contact lens affected myopia progression in children aged 8–12 at the initiation of treatment5. After three years, the study concluded the lens effectively slowed myopia progression by an average of 59% and slowed the rate at which the eye lengthens by an average of 52% compared to children in the control group wearing a single-vision 1-day lens.5 Results presented after the five-year mark continued to demonstrate safety and efficacy.6
Incorporating this technology into a 1-day disposable lens was based on the safety profile of lenses that are discarded after one day of use, as well as children’s ease of use and parental peace of mind. For children and parents, a multi-center study found:
Click here to view the entire document from CooperVision
* Indications for Use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.
1. Compared to a single vision 1 day lens over a 3 year period. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8): 556-567.
2. British Contact Lens Association (BCLA) (2019, May 17). Retrieved October 2, 2019, from https://www.bcla.org.uk/Public/News/Press_Release/Finalists-unveiled-for-2019-BCLA-Awards.aspx
3. La liste des nominés aux 26e SILMO d’Or. (2019, September 25). Retrieved October 2, 2019, from https://en.silmoparis.com/Silmo-d-Or-Awards/Nominees-2019.
4. Optician. (2018, April 4). Optician Awards 2018: Black ties and glittering prizes. Retrieved October 2, 2019, from https://www.opticianonline.net/news/optician-awards-2018-black-ties-and-glittering-prizes.
5. Compared to a single vision 1 day lens. Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8): 556-567.
6. CooperVision data on file 2019. How much do you like wearing your contact lenses? 87/97 (90%) Top box ‘I like contact lenses the best’ Subjective response @60M.
7. As reported by parents.
8. CooperVision data on file 2018. Overall experience as defined as children’s comfort, vision, lens handling, and freedom from spectacles. Children aged 8-15 years. 3-year study report.